SecBot SecBot
8-K ·Filed Jun 2, 2026

HIMS

Hims & Hers Health, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed4mo ago SEC0001773751-26-000091
8-K material event: Items 1.01
Actionable Insight ▲ Bullish

The acquisition closes a key strategic international expansion, but without disclosed financials the near-term EPS impact is unclear. Monitor the next quarterly report for initial revenue contribution from Eucalyptus and any guidance update. The credit amendment provides balance sheet flexibility, reducing near-term financing risk.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
HIMS ▲ +8.43% at T+60d
LONG call ✓ call won +8.43% · α vs SPY +7.32% · entry $27.51 → $29.83
Entry = T+0 close
Jun 2, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.69%
$27.51
settled 5mo ago
T+5d
+5.34%
call +5.34% · α +8.31%
$28.98
settled 5mo ago
T+20d
+36.57%
call +36.57% · α +38.13%
$37.57
settled 4mo ago
T+60d
+8.43%
call +8.43% · α +7.32%
$29.83
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Hims & Hers completed its acquisition of Eucalyptus, an Australian digital health platform, expanding its presence to Australia, Canada, Germany, Japan, and the UK. The company concurrently amended its revolving credit facility to provide covenant relief and increase downstream investment capacity, supporting the deal. The acquisition reinforces management's long-term revenue target of $6.5 billion and Adjusted EBITDA of $1.3 billion by 2030.

Key Financial Metrics

Deal Type
acquisition

Key Facts

  • Completed acquisition of Eucalyptus on June 2, 2026
  • Eucalyptus has served >850,000 customers to date
  • Amendment No. 3 to credit agreement provides 150-day clean-up period for Eucalyptus integration
  • Increased downstream investment capacity in non-loan party subsidiaries
  • Company reaffirms long-term targets of $6.5B revenue and $1.3B Adjusted EBITDA by 2030

Financial Impact

Acquisition extends global footprint but deal value not disclosed; credit facility remains $175 million with no material change to interest rates or covenants

revenueebitdasubscriber count

Risk Factors

  • Integration challenges across multiple new geographies and regulatory environments
  • Failure to achieve the aspirational 2030 revenue/EBITDA targets
  • Potential dilution if further debt or equity needed to fund international growth

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
43% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001773751-26-000091
Exhibit: ex991pressreleaserercfeuc.htm0001773751-26-000091
Document: hims-20260529.htm0001773751-26-000091
Document: 0001773751-26-000091-index-headers.html0001773751-26-000091
Document: 0001773751-26-000091-index.html0001773751-26-000091
Document: 0001773751-26-000091.txt0001773751-26-000091
19 reports for HIMS
Performance horizon
50% Hit rate @ T+20 2 of 4 directional calls Went positive at some point 3 of 4 best @ T+5▲ +10.95%May 11, 2026
Filters
Rows
Reports for HIMS — sortable, filterable
TypeNow
Oct 27, 2026
today
Institutional Cluster
NEUTRAL ★ 2/10
$28.18awaiting T+20—$27.92 (−0.92%)
Oct 7, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$28.06awaiting T+20—$27.92 (−0.50%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 5/10
$29.28 $29.13▲ +0.51%▲ +0.09%$27.92 (+4.64%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$29.35 $28.15▲ +4.09%▲ +3.18%$27.92 (+4.87%)
Sep 17, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$27.99 $28.07▼ −0.29%▼ −0.08%$27.92 (+0.25%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.92 (−17.35%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.92 (−17.35%)
Aug 18, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.09 $27.89▼ −10.29%▼ −9.45%$27.92 (−10.20%)
Aug 10, 2026
11w ago
8-K
MIXED ★ 7/10
$30.51 $27.90▼ −8.55%▼ −7.50%$27.92 (−8.49%)
Jul 1, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$36.80 $27.04▼ −26.52%▼ −26.11%$27.92 (−24.13%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (16h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026